ER-DPExtended-Release Dipyridamole
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(55) Aspirin plus ER-DP reduced stroke risk by 23% over aspirin alone.
In progress now are trials validating ESPS2, comparing clopidogrel plus aspirin with aspirin alone, and comparing combination aspirin plus ER-DP with clopidogrel.
Until these trials are complete, reasonable first-line choices for secondary stroke prevention are aspirin alone or in combination with ER-DP. For patients unable to take aspirin, consider giving clopidogrel alone.